Saturday 17 October 2026 Export RYTM’s income statement to Excel — free account

Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $189.8 million, up 45.8% from fiscal 2024. In the quarter to June 2026, revenue grew 46.9%, EPS grew 2.67% and free cash flow grew 60.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

86.17 1.80 −2.05%

Follow RYTM

Alert me

Market cap: $6.1B
P/E: 0.0×
Fwd P/E: −26.9×
Dividend yield: —
F-score: 6/9
Altman Z: 15.89
Beneish M: −2.93
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	4	5	6	6	+8 more TTM periods Free account
ROE Full definition →	(461.65%)	(293.04%)	(251.14%)	(247.13%)
ROA Full definition →	(51.91%)	(50.14%)	(46.29%)	(45.44%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(69.36%)	(63.37%)	(55.77%)	(50.60%)
Average Days of Receivables Full definition →	61.47	57.47	50.17	69.16
Free Cash Flow per Share Full definition →	(1.54)	(1.76)	(2.42)	(2.26)
Free Cash Flow Full definition →	(105.35)	(119.51)	(157.13)	(149.63)
Capital Expenditures Full definition →	—	—	(41.45)	(40.50)
Other line items
Cash ROIC Full definition →	(19.22%)	(20.67%)	(23.84%)	(21.02%)
Accounts Receivable Turnover Full definition →	7.21	8.35	8.51	6.66
Accounts Payable Turnover Full definition →	1.64	1.90	1.48	2.00
Inventory Turnover Full definition →	1.07	0.96	0.88	1.03
Average Days of Payables Full definition →	223.59	195.17	261.17	269.29
Days of Inventory on Hand Full definition →	422.10	454.66	482.24	436.73
Tax Rate Full definition →	0.01	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	72.20%	79.24%	88.19%	95.49%
Selling, General and Administrative Expense of Revenue Full definition →	100.43%	101.05%	102.73%	100.72%
Share Based Compensation of Revenue Full definition →	36.36%	35.48%	35.21%	33.33%
Interest Coverage Full definition →	(10.86)	(9.99)	(9.33)	(8.48)
Operating CF/Net income Full definition →	0.50	0.58	0.57	0.55
Depreciation/Fixed assets Full definition →	10.48	1.13	1.21	6.11
Capex/Depreciation Full definition →	0.00	0.00	(30.98)	(27.95)
Revenue per Share Full definition →	3.50	3.19	2.92	2.63
Operating CF per Share Full definition →	(1.54)	(1.76)	(1.78)	(1.65)
Capex per Share Full definition →	0.00	0.00	(0.64)	(0.61)
Capex to Sales Full definition →	0.00	0.00	0.22	0.23

Show all line items

Columns are period end dates

Stockrow Weekly